Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples

Edith Nakku-Joloba, Emily E Pisarski, Monique A Wyatt, Timothy R Muwonge, Stephen Asiimwe, Connie L Celum, Jared M Baeten, Elly T Katabira, Norma C Ware, Edith Nakku-Joloba, Emily E Pisarski, Monique A Wyatt, Timothy R Muwonge, Stephen Asiimwe, Connie L Celum, Jared M Baeten, Elly T Katabira, Norma C Ware

Abstract

Introduction: Pre-exposure prophylaxis (PrEP) to prevent HIV infection is being rolled out in Africa. The uptake of PrEP to date has varied across populations and locations. We seek to understand the drivers of demand for PrEP through analysis of qualitative data collected in conjunction with a PrEP demonstration project involving East African HIV serodiscordant couples. Our goal was to inform demand creation by understanding what PrEP means - beyond HIV prevention - for the lives of users.

Methods: The Partners Demonstration Project evaluated an integrated strategy of PrEP and antiretroviral therapy (ART) delivery in which time-limited PrEP served as a "bridge" to long-term ART. Uninfected partners in HIV serodiscordant couples were offered PrEP at baseline and encouraged to discontinue once infected partners had taken ART for six months. We conducted 274 open-ended interviews with 93 couples at two Ugandan research sites. Interviews took place one month after enrolment and at later points in the follow-up period. Topics included are as follows: (1) discovery of serodiscordance; (2) decisions to accept/decline PrEP and/or ART; (3) PrEP and ART initiation; (4) experiences of using PrEP and ART; (5) PrEP discontinuation; (6) impact of PrEP and ART on the partnered relationship. Interviews were audio-recorded and transcribed. We used an inductive, content analytic approach to characterize meanings of PrEP stemming from its effectiveness for HIV prevention. Relevant content was represented as descriptive categories.

Results: Discovery of HIV serodiscordance resulted in fear of HIV transmission for couples, which led to loss of sexual intimacy in committed relationships, and to abandonment of plans for children. As a result, partners became alienated from each other. PrEP countered the threat to the relationship by reducing fear and reinstating hopes of having children together. Condom use worked against the re-establishment of intimacy and closeness. By increasing couples' sense of protection against HIV infection and raising the prospect of a return to "live sex" (sex without condoms), PrEP was perceived by couples as solving the problem of serodiscordance and preserving committed relationships.

Conclusions: The most effective demand creation strategies for PrEP may be those that address the everyday life priorities of potential users in addition to HIV prevention.

Clinical trial number: NCT02775929.

Keywords: East Africa; HIV; PrEP; demand creation; prevention; serodiscordant couples.

© 2019 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

References

    1. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.
    1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–99.
    1. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423–34.
    1. Baeten JM, Heffron R, Kidoguchi L, Mugo NR, Katabira E, Bukusi EA, et al. Integrated delivery of antiretroviral treatment and pre‐exposure prophylaxis to HIV‐1‐serodiscordant couples: a prospective implementation study in Kenya and Uganda. PLoS Med. 2016;13(8):e1002099.
    1. The South African National AIDS Council . The South African National Sex Worker HIV Plan, 2016‐2019. Pretoria, South Africa: 2016 [Internet] [cited 2018 Jun 21]. Available from:
    1. The South African National AIDS Council . Let Our Actions Count: South Africa's National Strategic Plan for HIV, TB and STIs [Internet] [cited 2018 Jun 21]. Available from:
    1. National AIDS & STI Control Programme (NASCOP), Ministry of Health . Framework for the Implementation of Pre‐exposure Prophylaxis of HIV in Kenya, Nairobi, Kenya: NASCOP [Internet]. 2017. [cited 2018 Jun 21]. . Available from:
    1. UNAIDS . Kenya launches self‐test kits and PrEP[Internet] [cited 2018 Jun 21]. Available from:
    1. Ministry of Health . Consolidated Guidelines for Prevention and Treatment of HIV in Uganda[Internet]. 2016. [cited 2018 Jun 21]. Available from:
    1. AVAC . PrEPWatch Country Updates [Internet].[cited 2018 Oct 25]. Available from:
    1. AVAC Global PrEP Initation Tracker, Jul, 2018 Update [Internet] [cited 2018 Oct 22]. Available from:
    1. Pillay Y. Challenges of South Africa's sex worker PrEP programme: Lessons learned, moving towards to other key populations. 22nd International AIDS Conference; 2018 Amsterdam, the Netherlands; Jul 23‐27.
    1. Kyono JK, Kiragu M, Karuga R, Ochieng C, Ngunjiri A, Wachihi C, et al. How long will they take it? Oral pre‐exposure prophylaxis (PrEP) retention for female sex workers, men who have sex with men and young women in a demonstration project in Kenya. 22nd International AIDS Conference; 2018 Jul 23‐27; Amsterdam, the Netherlands.
    1. Pillay D, Jenkins S, Murire M, Stankevitz K, Subedar H, Mullick S. Factors influencing initiation, continuation & discontinuation of oral PrEP at selected facilitites in South Africa. 22nd International AIDS Conference; 2018 Jul 23‐27; Amsterdam, the Netherlands.
    1. Mugwanya K, Pintye J, Kinuthia J, Abuna F, Lagat H, Serede M, et al. Uptake of PrEP within clinics providing integrated family planning and PrEP services: Results from a large implementation program in Kenya. 22nd International AIDS Conference; 2018 Jul 23‐27; Amsterdam, the Netherlands.
    1. Gombe MM, Mangwendeza Y, Ncube G, Zwangobani N, Prust M, Cakouros B, et al. Integrating oral HIV pre‐exposure prophylaxis (PrEP) in a public family planning facility and youth center to inform national roll out in Zimbabwe. 22nd International AIDS Conference; 2018 Jul 23‐27; Amsterdam, the Netherlands.
    1. Ferrigno B. What is demand creation? Insight to impact: Driving demand creation for HIV Prevention. 22nd International AIDS Conference; 2018 Jul 23‐27; Amsterdam, the Netherlands.
    1. Heffron R, Ngure K, Odoyo J, Bulya N, Tindimwebwa E, Hong T, et al. Pre‐exposure prophylaxis for HIV‐negative persons with partners living with HIV: uptake, use, and effectiveness in an open‐label demonstration project in East Africa. Gates Open Res. 2017;1:3 10.12688/gatesopenres.12752.1.
    1. Kahle EM, Hughes JP, Lingappa JR, John‐Stewart G, Celum C, Nakku‐Joloba E, et al. An empiric risk scoring tool for identifying high‐risk heterosexual HIV‐1‐serodiscordant couples for targeted HIV‐1 prevention. J Acquir Immune Defic Syndr. 2013;62:339–47.
    1. Morton JF, Celum C, Njoroge J, Nakyanzi A, Wakhungu I, Tindimwebwa E, et al. Counseling framework for HIV‐serodiscordant couples on the integrated use of antiretroviral therapy and pre‐exposure prophylaxis for HIV prevention. J Acquir Immune Defic Syndr. 2017;74 Suppl 1:S15–22.
    1. Patton MQ. Qualitative research and evaluation methods. 3rd ed Thousand Oaks, CA: Sage Publications; 2002.
    1. Hsieh HS, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277–88.
    1. Ngure K, Heffron R, Curran K, Vusha S, Ngutu M, Mugo N, et al. ‘I Knew I Would Be Safer.’ Experiences of Kenyan HIV serodiscordant couples soon after pre‐exposure prophylaxis (PrEP) initiation. AIDS Patient Care STDs. 2016;30(2):78–83.
    1. Patel RC, Stanford‐Moore G, Odoyo J, Pyra M, Wakhungu I, Anand K, et al. ‘Since both of us are using antiretrovirals, we have been supportive to each other’: facilitators and barriers of pre‐exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya. J Int AIDS Soc. 2016;19(1):21134.
    1. Patel RC, Leddy AM, Odoyo J, Anand K, Stanford‐Moore G, Wakhungu I, et al. What motivates serodiscordant couples to prevent HIV transmission within their relationships: findings from a PrEP implementation study in Kenya. Cult Health Sex. 2017;14:1–15.
    1. Pintye J, Beima‐Sofe KM, Kimemia G, Ngure K, Trinidad SB, Heffron RA, et al. ‘I did not want to give birth to a child who has HIV’: experiences using PrEP during pregnancy among HIV‐uninfected Kenyan women in HIV‐serodiscordant couples. J Acquir Immune Defic Syndr. 2017;76(3):259–65.
    1. Ware NC, Wyatt MA, Haberer JE, Baeten JM, Kintu A, Psaros C, et al. What's love got to do with it? Explaining adherence to oral antiretroviral pre‐exposure prophylaxis for HIV‐serodiscordant couples. J Acquir Immune Defic Syndr. 2012;59(5):463–8.
    1. Koester KA, Erguera XA, Myers JJ. ‘PrEP makes my relationship even more normal’: the discursive production of hope in the context of HIV pre‐exposure prophylaxis among young adults with partners living with HIV infection In: Persson A, Hughes S, editors. Cross‐cultural perspectives on couples with mixed HIV status: beyond positive/negative. Social aspects of HIV. New York: Springer International Publishing Company; 2016. p. 23–35.
    1. Rivierez I, Quatremere G, Spire B, Ghosn J,Rojas Castro D. Lessons learned from the experiences of informal PrEP users in France: results from the ANRS‐PrEPage study. AIDS Care. 2018;30 Supp 2:48–53.
    1. Koester K, Amico RK, Gilmore H, Liu A, McMahan V, Mayer K, et al. Risk, safety and sex among male PrEP users: time for a new understanding. Cult Health Sex. 2017;19(12):1301–13.
    1. Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles’ heel of innovations in HIV prevention? BMJ. 2006;332(7541):605–7.
    1. Blumenthal J, Haubrich R. Risk compensation in PrEP: an old debate emerges yet again. Virtual Mentor. 2014;16:909–15.
    1. Bekker LG. Five Controversies in PrEP Scale‐up. XXV Conference on Retroviruses and Opportunistic Infections; 2018 March 4‐7; Boston, MA.
    1. Traeger MW, Schroeder SE, Wright EJ, Hellard ME, Cornelisse VJ, Doyle JS, et al. Effects of pre‐exposure prophylaxis for the prevention of HIV infection on sexual risk behavior in men who have sex with men: a systematic review and meta‐analysis. Clin Infect Dis. 2018;67(5):676–86.
    1. Hoff CC, Chakravarty D, Bircher AE, Campbell CK, Grisham K, Neilands TB, et al. Attitudes towards PrEP and anticipating condom use among concordant HIV‐negative and HIV‐discordant male couples. AIDS Patient Care STDs. 2015;29(7):408–17.
    1. Mujugira A, Celum C, Ngure K, Thomas KK, Katabira E, Baeten JM, et al. Antiretroviral therapy initiation is not associated with risky sexual behavior among heterosexual human immunodeficiency virus‐infected persons in serodiscordant partnerships. Sex Transm Dis. 2017;44(1):57–61.
    1. Grant RM, Anderson PL. Uptake of pre‐exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820–9.
    1. Persson A. Notes on the concepts of ‘serodiscordance’ and ‘risk’ in couples with mixed HIV status. Glob Public Health. 2013;8(2):209–20.
    1. Rhodes T, Cusick L. Love and intimacy in relationship risk management: HIV positive people and their sexual partners. Sociol Health Illn. 2000;22(1):1–26.
    1. Wyatt MA, Pisarski EE, Tam M, Nakku‐Joloba E, Muwonge TR, Katabira ET, et al. Experiences of PrEP Discontinuation in African HIV Serodiscordant Couples: Qualitative results from the Partners Demonstration Project. AIDS 2016 Jul 18‐22; Durban, South Africa.
    1. Carroll JJ, Ngure K, Heffron R, Curran K, Mugo NR, Baeten JM. Gendered differences in the perceived risks and benefits of oral PrEP among HIV serodiscordant couples in Kenya. AIDS Care. 2016;8:1000–6.
    1. Grant RM, Koester KA. What people want from sex and pre‐exposure prophylaxis. Curr Opin HIV AIDS. 2016;11:3–9.
    1. Hartmann M, McConnell M, Bekker LG, Celum C, Bennie T, Zuma J, et al. Motivated reasoning and HIV risk? Views on relationships, trust and risk from young women in Cape Town, South Africa, and implications for oral PrEP. AIDS Behav. 2018;22(11):3468–79.
    1. Golub S. PrEP messaging: Taking “Risk” out of the pitch. HIV Research for Prevention Conference; 2018 Oct 21‐25; Madrid, Spain.
    1. Beyeza‐Kashesya J, Kaharuza F, Mirembe F, Neema S, Ekstrom AM, Kulane A. The dilemma of safe sex and having children: challenges facing HIV serodiscordant couples in Uganda. Afr Health Sci. 2009;9(1):2–12.
    1. Mugo N. Taking the leap in PrEP scale‐up: a good type of challenge. XXV Conference on Retroviruses and Opportunistic Infections; 2018 Mar 4‐7; Boston, MA.
    1. Torjesen K, Rees H, Warren M. Insight to impact: Driving demand creation for HIV prevention. 22nd International AIDS Conference; 2018 Jul 23‐27; Amsterdam, the Netherlands.
    1. Amico KR, Wallace M, Bekker LG, Roux S, Atujuna M, Sebastian E, et al. Experiences with HPTN 067/ADAPT study‐provided open‐label PrEP among women in Cape Town: facilitators and barriers within a mutuality framework. AIDS Behav. 2017;21(5):1361–75.
    1. Eakle R, Bourne A, Mbogua J, Mutanha N, Rees H. Exploring acceptability of oral PrEP prior to implementation among female sex workers in South Africa. J Int AIDS Soc. 2018;21(2):e25081.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe